CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ANIK — Anika Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ANIK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,658,661
-$124 QoQ
Shares Held
113,374
-0.9% QoQ
Ownership
0.847%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. ANIK ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in ANIK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,658,661 | 113,374 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,658,785 | 114,399 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,021,514 | 106,297 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $976,378 | 103,870 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,407,637 | 133,047 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,253,523 | 149,935 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,262,624 | 137,462 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,703,913 | 149,956 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,803,147 | 150,144 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,717,747 | 146,368 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,677,437 | 118,157 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,116,572 | 113,611 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,916,229 | 112,249 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,173,531 | 110,499 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,290,306 | 111,159 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,594,366 | 109,007 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,322,887 | 104,072 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,615,206 | 104,150 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,639,253 | 101,570 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,322,606 | 101,565 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,313,761 | 99,648 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,836,347 | 118,567 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,139,318 | 113,551 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,014,323 | 113,431 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,291,712 | 113,748 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,340,203 | 115,538 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||